| Analysis | Metabolite Name | Measured Value | Units | Model | Intervention |
|---|---|---|---|---|---|
| Normal phase UNSPECIFIED ION MODE | N-Acetylneuraminic acid | 0.00019 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | N-Acetylneuraminic acid | 0.00023 | peak area | Wild type | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | N-Acetylneuraminic acid | 0.00024 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | N-Acetylneuraminic acid | 0.00024 | peak area | Wild type | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | N-Acetylneuraminic acid | 0.00025 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | N-Acetylneuraminic acid | 0.00025 | peak area | Wild type | Saline |
| Normal phase UNSPECIFIED ION MODE | N-Acetylneuraminic acid | 0.00026 | peak area | Wild type | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | N-Acetylneuraminic acid | 0.00026 | peak area | Wild type | Saline |
| Normal phase UNSPECIFIED ION MODE | N-Acetylneuraminic acid | 0.00028 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | N-Acetylneuraminic acid | 0.00029 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | N-Acetylneuraminic acid | 0.00031 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | N-Acetylneuraminic acid | 0.00032 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | N-Acetylneuraminic acid | 0.00036 | peak area | Wild type | Saline |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|